Raxitkumar Jinjuvadia1, Chetna Jinjuvadia2, Pimpitcha Puangsricharoen3,4, Naga Chalasani3, David W Crabb3,5,6, Suthat Liangpunsakul3,5,7. 1. Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan. 2. Division of Pulmonology and Critical Care Medicine, Department of Medicine, Wayne State University, Detroit, Michigan. 3. Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, Indiana. 4. Chulalongkorn University, Faculty of Medicine, Bangkok, Thailand. 5. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana. 6. Eskenazi Health, Indianapolis, Indiana. 7. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.
Abstract
BACKGROUND: Despite that the epidemiological studies on the comorbidity of alcohol misuse and psychiatric disorders have been studied, less is known about the magnitude of these disorders among patients with alcoholic liver disease (ALD). Our aim was to determine the prevalence of psychiatric and substance use disorders among hospitalized ALD patients in the United States. METHODS: We utilized a single-level clinical classification software to identify patients with ALD and psychiatric/substance use disorders from the 2011 National Inpatient Sample data. The primary outcome was the prevalence of these disorders among hospitalized patients with ALD (n = 74,972) compared to those with chronic liver diseases not caused by alcohol (n = 350,140) and those without underlying liver diseases (n = 1,447,063). RESULTS: The prevalence of adjustment disorder, anxiety disorder, posttraumatic stress disorder, and depression was significantly higher among hospitalized patients with ALD when compared to those with chronic liver diseases not caused by alcohol (all with p-values <0.05). Younger age, female gender, and White race were the independent predictors of psychiatric/substance use disorders among hospitalized patients with ALD. CONCLUSIONS: Hospitalized patients with ALD have significantly high prevalence of concomitant psychiatric and substance abuse disorders when compared to those with chronic liver diseases not caused by alcohol and those without underlying liver diseases. Screening and appropriate intervention should be implemented as part of routine clinical care for these patients.
BACKGROUND: Despite that the epidemiological studies on the comorbidity of alcohol misuse and psychiatric disorders have been studied, less is known about the magnitude of these disorders among patients with alcoholic liver disease (ALD). Our aim was to determine the prevalence of psychiatric and substance use disorders among hospitalized ALDpatients in the United States. METHODS: We utilized a single-level clinical classification software to identify patients with ALD and psychiatric/substance use disorders from the 2011 National Inpatient Sample data. The primary outcome was the prevalence of these disorders among hospitalized patients with ALD (n = 74,972) compared to those with chronic liver diseases not caused by alcohol (n = 350,140) and those without underlying liver diseases (n = 1,447,063). RESULTS: The prevalence of adjustment disorder, anxiety disorder, posttraumatic stress disorder, and depression was significantly higher among hospitalized patients with ALD when compared to those with chronic liver diseases not caused by alcohol (all with p-values <0.05). Younger age, female gender, and White race were the independent predictors of psychiatric/substance use disorders among hospitalized patients with ALD. CONCLUSIONS: Hospitalized patients with ALD have significantly high prevalence of concomitant psychiatric and substance abuse disorders when compared to those with chronic liver diseases not caused by alcohol and those without underlying liver diseases. Screening and appropriate intervention should be implemented as part of routine clinical care for these patients.
Authors: Augustin G L Vannier; Vladislav Fomin; Raymond T Chung; Suraj J Patel; Esperance Schaefer; Russell P Goodman; Jay Luther Journal: Gastro Hep Adv Date: 2022-03-30
Authors: David Uihwan Lee; Harrison Chou; Edwin Wang; Gregory Hongyuan Fan; John Han; Kevin Chang; Jean Kwon; Ki Jung Lee; Jeremy Blanchard; Nathalie Helen Urrunaga Journal: Expert Rev Gastroenterol Hepatol Date: 2022-06-19 Impact factor: 4.095